Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
NCT00969319
·
clinicaltrials.gov ↗
COMPLETED
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Blood Coagulation Disorders
Hemophilia A
Interventions
BIOLOGICAL:
Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Sponsor
Bayer